Dr. Sivaprakash Ramalingam
Siva received his doctorate in Biotechnology from University of Madras, Chennai, India. After a brief stint at Pharma Company, Orchid Pharma Ltd, Chennai, as a Research Scientist, he pursued his post-doctoral studies in the laboratory of gene-editing pioneer and inventor of zinc finger nucleases Prof. Chandra at Johns Hopkins University School of Public Health, Baltimore, USA, with research focus on pluripotent stem cell engineering. During his post-doctoral research, he received MSCRF exploratory grant award from Maryland Stem Cell Research Fund in 2012 and then worked as a Junior Faculty at Johns Hopkins School of Public Health. He then returned to India with Ramalingaswami Fellowship Award from Department of Biotechnology and joined CSIR-IGIB in 2017 as a Senior Scientist.
Sangam Giri Goswami
Nupur finished her undergraduate studies at Miranda House, University of Delhi. She then went onto pursue her post-graduation in Biomedical Sciences at King’s College, London. Since early 2017, she has been working with Dr. Sivaprakash Ramlingam working on generation, and characterization of disease-specific iPSCs. In 2019,she started her PhD which aims at recapitulating beneficial mutations in disease model system for beta hemoglobinopathies. She likes to read in her free time.
Aditya Ramdas Iyer
Dr. Neelam Lohani
Shashank did his bachelor’s in Biochemistry from Deshbandhu College, University of Delhi and his Masters in Biotechnology (M.Sc.) from Madurai Kamaraj University. His research interest lies in understanding the molecular aspects of reprogramming and using gene editing for therapeutic purposes. He is currently doing PhD from Max Planck Institute for Molecular Medicine, Gesellschaft, Germany. In his free time he likes to follow Formula 1 and geopolitical news.
Thulasi joined the lab as a research fellow in May 2019. Prior to that, she completed her Bachelor’s in Biotechnology (B.Tech) at Rajalakshmi Engineering College, Anna University in 2016 and Master’s in Biotechnology (M.Tech) at PSG College of Technology, Anna University in 2018. She was working on generating an adoptive CAR-T cell platform using iPScs and developing CRISPR based diagnostics for Beta Thalasemmia. In her free time, Thulasi likes to play badminton and read books.